The results showed statistically significant but clinically modest weight loss (2kg average advantage over placebo at the 1mg oral dose over 23 weeks)
AOD9604 and Oral Bioavailability Research Pharmacokinetic profiling in pigs confirmed that AOD9604 is orally bioavailable, with intact peptide and its principal N-terminal truncation degradants (2aa and 3aa fragments) detected in plasma following oral dosing
Look for reduced inflammation within the first week, visible wound size reduction by week 2-3, and accelerated re-epithelialization compared to similar past wounds
Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation
For best results, administer the injection in the upper arm, thigh, or buttocks using a clean, sterile syringe
Female-focused study contexts Research examining peptides for female fat loss generally accounts for a different hormonal baseline, since estrogen levels are understood in the literature to influence fat distribution patterns differently than in male physiology particularly around subcutaneous versus visceral fat storage